CEACAM5 and neoplasm: For years, and in several cancer types, we have used different tumor protein markers such as CA 15.3, CA 125, prostate-specific antigen (PSA), or carcinoembryonic antigen (CEA) to detect disease recurrence, progression, and response to therapy [93].